After the treatment with 5a, the upregulation of p21 gene expression and p53 protein expression confirmed the antineoplastic effect of 5a toward human breast cancer cells by suppressing the RAS/PI3K/Akt signaling pathway. This evidence concerns the gene AKT1 and breast carcinoma.